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Throughout development, proliferative progenitors lose their mitotic potential, exit the cell cycle,
and differentiate. In this issue, Ruijtenberg and van den Heuvel identify an important lineage-
specific role for a SWI/SNF chromatin-remodeling complex that collaborates with core cell-cycle
regulators to promote cell-cycle exit and terminal muscle cell differentiation.There are a wide variety of molecular
mechanisms that ensure faithful entry,
progression, and exit during the cell
cycle. These tightly regulated mecha-
nisms include activation and inactivation
of cyclin-dependent kinases (CDKs),
expression and degradation of cyclins,
and expression of inhibitors of CDK-cyclin
complexes. Deregulation of cell-cycle
control is a hallmark of many human
malignancies. Ruijtenberg and van den
Heuvel now reveal that, in a cell lineage-
specific fashion, a SWI/SNF chromatin-
remodeling complex genetically interacts
with core G1/S cell-cycle regulators and
plays an important and redundant role in
muscle cell-cycle exit and muscle differ-
entiation in C. elegans (Ruijtenberg and
van den Heuvel, 2015).
To study cell-cycle exit in vivo, the au-
thors developed a conditional knockout
and lineage-tracing system in C. elegans.
Optimizing several aspects of the estab-
lished Cre/lox-based technologies for
gene knockout and lineage tracing, the
authors established a faithful system for
inactivating a gene of interest in a partic-
ular lineage and following the mutant
cells and their progeny. The method
involves generating a homozygous geno-
mic mutation of the gene of interest and
then integrating a single-copy transgene
encoding a floxed wild-type copy of the
gene along with the fluorescent protein
reporters, mCherry and GFP. The wild-
type copy of the gene and mCherry are
expressed while GFP is silent. Sub-
sequent expression of CRE recombinase
from tissue-specific promoters leads to
deletion of the floxed gene in a particular
lineage while activating GFP, allowing
identification of mutant cells. This elegant
technique allowed them to dissect themechanism of cell-cycle exit in different
lineages and furthermore to screen for
chromatin regulators of this process
during muscle terminal differentiation.
Applying this approach to intestinal and
muscle cell lineages, the authors uncov-
ered lineage-specific differences in the
requirements for cell-cycle regulators to
induce differentiation and quiescence.
Loss of the G1/S inhibitors lin-35/Rb
and fzr-1/Cdh1 in intestinal cells results
in failure of cell-cycle exit and extra cell
divisions (hyperplasia), whereas loss of
these inhibitors does not alter the cell
division and differentiation pattern of
postembryonic mesoderm (M) lineage,
which gives rise to muscle cells. These
findings point to the participation of
other cell-cycle exit regulators that remain
in place even in the absence of Rb and
Cdh1.
To address this question, the authors
performed a candidate-based RNAi
screen on animals lacking lin-35/Rb
and fzr-1/Cdh1. The screen hits included
the known CDK inhibitors CKI-1 and
Kip1 and two SCF-like E3 ubiquitin ligase
subunits. What they further discovered
were members of the SWI/SNF chro-
matin-remodeling complex. The loss of
SWI/SNF function in the absence of Rb
and Cdh1 abrogated cell-cycle exit in
the M lineage, but not in the intestine,
revealing unexpected, differential mecha-
nisms at play that control the cell cycle
in different cell lineages. This finding
raised the interesting question of what
function a chromatin remodeler could
have in regulating lineage-specific cell-
cycle arrest during differentiation.
SWI/SNF complexes remodel chro-
matin structure by moving or ejecting
nucleosomes to provide or potentiallyCellblock access to DNA at target genes
(Cairns, 2009). This remodeler has gained
attention from the cancer community as
SWI/SNF subunits are mutated in 19.6%
of all human tumors, as reported in
44 studies (Kadoch et al., 2013). For
instance, SNF5 mutations are found in
nearly all rhabdoid tumors, BAF180 muta-
tions in 41% of renal cell carcinomas,
ARID1Amutations in 50% of ovarian clear
cell carcinomas, and BRG1 mutations in
15%–50% of human primary non-small-
cell lung cancer samples (Wilson and
Roberts, 2011). However, the molecular
mechanisms by which SWI/SNF com-
plexes participate in the regulation of cell
proliferation and tumorigenesis are not
fully understood.
Multiple studies have hinted at essential
roles for chromatin remodeling in cell-
cycle regulation and differentiation. For
instance, a whole-mouse knockout of
one SWI/SNF component, Brm, resulted
in hyperplasia of select organs and
increased cellular proliferation (Reyes
et al., 1998). Recently, the human SWI/
SNF subunit BAF47 has been reported to
be required for cell-cycle withdrawal by
silencing cyclin D1 during skeletal muscle
terminal differentiation (Joliot et al., 2014).
These studies, in composite, suggest a
role for chromatin remodeling in promot-
ing cell-cycle exit and differentiation,
although the nature and extent of the
requirement has varied between studies.
Furthermore, the precise interactions of
chromatin remodelers and other cell-cy-
cle regulatory pathways remains ambig-
uous: in some cases, SWI/SNF appears
to act in concert with Rb to regulate the
cell cycle (Zhang et al., 2000), while in
others it primarily induces a differentiation
program (de la Serna et. al., 2001).162, July 16, 2015 ª2015 Elsevier Inc. 237
Figure 1. SWI/SNF Complex Regulates Cell-Cycle Exit and Differentiation of Muscle Cells in
C. elegans
The SWI/SNF complex plays a lineage-specific role in cell-cycle regulation in the mesoblast (M) lineage,
but not in intestinal cells, during terminal differentiation. This complex has both positive and negative
effects on gene expression, being required for inhibiting positive cell-cycle regulators like CYE-1 and
CDK-4 and activating negative regulators such as CKI-1 and CDC-14. In addition, the authors demon-
strate that SWI/SNF acts in concert with MyoD and antagonizes Polycomb-mediated transcriptional
repression (not shown). These interactions, in composite, promote exit of M cells from the cell cycle and
terminal differentiation of muscle cells.In the current study, Ruijtenberg and
van den Heuvel demonstrate, in whole
animals, that the SWI/SNF-remodeling
complex regulates expression of both
positive and negative regulators of cell
cycle during muscle differentiation in
the M lineage. Expression of positive
cell-cycle regulators cye-1 cyclin E and
cdk-4 increased, while expression of
negative regulators of cell cycle cki-1
and cdc-14, and muscle-specific genes
such asmyo-3, decreased in the absence
of an intact (likely muscle cell-specific)
SWI/SNF complex (Figure 1). Surprisingly,
SWI/SNF provided a layer of regulation
on top of Rb-induced cell-cycle arrest
in M cells, in contrast to other systems
where the effects of chromatin and Rb
are largely inter-dependent (Harel-Bellan
et al., 1998; Zhang et al., 2000). These
findings integrate the previous reports
of SWI/SNF requirements for cell-cycle238 Cell 162, July 16, 2015 ª2015 Elsevier Inexit, induction of lineage-specific tran-
scription programs, and interplay with
the classical cell-cycle regulators. The
combined inactivation of cell-cycle genes
and SWI/SNF resulted in tumor-like
over-proliferation of M cells, mimicking
a cancerous state in this simple model
system.
This study represents an important
step in understanding in vivo functions
of chromatin regulators in cell-cycle
control. It also raises many interesting
and exciting questions for future studies.
SWI/SNF complexes have been shown
to undergo changes in subunit com-
position during development (Lessard
et al. 2007), and presumably these
changes impart specific functions to
those SWI/SNF complexes with subtle
yet important biochemical differences.
Therefore, it will be important to know
the biochemical composition of thisc.muscle-cell-specific SWI/SNF complex.
Additional questions include: how is this
complex targeted to intended chromatin
locations? How does it specifically acti-
vate the expression of negative cell-cycle
regulators but repress positive regula-
tors? Is the chromatin-remodeling activity
of the complex required? Given the
central contribution of Rb, addressing
the molecular basis of its redundant
function with this SWI/SNF complex
should be investigated. Importantly,
the identification of SWI/SNF as an inde-
pendent and important cell-cycle regu-
lator will not only provide mechanistic
insights into chromatin remodeling in
regulating cell-cycle exit and differentia-
tion, but also open up new avenues in
the diagnosis and treatment of cancer.
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